Side effects of statins--prevalence, relevance, consequences.
Sinzinger
Helmut
H
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D000924:Anticholesteremic Agents / Q000009:adverse effects; D004796:Clinical Enzyme Tests; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D007172:Erectile Dysfunction / Q000139:chemically induced; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008099:Liver / Q000187:drug effects; D008148:Lovastatin / Q000009:adverse effects; D008297:Male; D009135:Muscular Diseases / Q000139:chemically induced; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D011725:Pyridines / Q000009:adverse effects; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D011725:Pyridines; D008148:Lovastatin; C086276:cerivastatin; D000410:Alanine Transaminase